OBJECTIVE: Hypoxia inducible factor α (HIF1-α) is a key protein regulating the response of a variety of genes and pathways, including angiogenesis, to hypoxic stimuli. High vascularity in various carcinomas correlates with invasion and metastasis. Assessment of primary tumor vascularity and HIF1-α expression in esophageal carcinomas was an objective of this study. METHODS: The vascularity in esophageal carcinomas (n=52) was quantified by Chalkley method on CD34 immunostained sections. HIF1-α expression was examined by immunohistochemistry. The relationships between CD34 Chalkley count, HIF1-α and various clinico-pathological characteristics with clinical outcome were evaluated. RESULTS: High HIF1-α expression in squamous cell carcinoma (SCC) was significantly associated with the T3-4 group (p=0.02). A higher percentage of SCC with high HIF1-α expression compared to its expression in adenocarcinoma (AC) (p=0.005) was observed. In the SCC group, high CD34 Chalkley count and high HIF1-α expression implied a significantly reduced survival (p=0.003 and p=0.001). No such significant association was found in the AC group. CONCLUSIONS: HIF1-α expression is different in two separate tumor microenvironments: SCCs and ACs of the esophagus. This suggests that different mechanisms may be involved in HIF1-α expression- and activity between the two histological types of esophageal carcinoma.
OBJECTIVE:Hypoxia inducible factor α (HIF1-α) is a key protein regulating the response of a variety of genes and pathways, including angiogenesis, to hypoxic stimuli. High vascularity in various carcinomas correlates with invasion and metastasis. Assessment of primary tumor vascularity and HIF1-α expression in esophageal carcinomas was an objective of this study. METHODS: The vascularity in esophageal carcinomas (n=52) was quantified by Chalkley method on CD34 immunostained sections. HIF1-α expression was examined by immunohistochemistry. The relationships between CD34 Chalkley count, HIF1-α and various clinico-pathological characteristics with clinical outcome were evaluated. RESULTS: High HIF1-α expression in squamous cell carcinoma (SCC) was significantly associated with the T3-4 group (p=0.02). A higher percentage of SCC with high HIF1-α expression compared to its expression in adenocarcinoma (AC) (p=0.005) was observed. In the SCC group, high CD34 Chalkley count and high HIF1-α expression implied a significantly reduced survival (p=0.003 and p=0.001). No such significant association was found in the AC group. CONCLUSIONS: HIF1-α expression is different in two separate tumor microenvironments: SCCs and ACs of the esophagus. This suggests that different mechanisms may be involved in HIF1-α expression- and activity between the two histological types of esophageal carcinoma.
Authors: Miles A Miller; Suresh Gadde; Christina Pfirschke; Camilla Engblom; Melissa M Sprachman; Rainer H Kohler; Katherine S Yang; Ashley M Laughney; Gregory Wojtkiewicz; Nazila Kamaly; Sushma Bhonagiri; Mikael J Pittet; Omid C Farokhzad; Ralph Weissleder Journal: Sci Transl Med Date: 2015-11-18 Impact factor: 17.956
Authors: Tara R Semenkovich; Roheena Z Panni; Jessica L Hudson; Theodore Thomas; Leisha C Elmore; Su-Hsin Chang; Bryan F Meyers; Benjamin D Kozower; Varun Puri Journal: J Thorac Cardiovasc Surg Date: 2018-01-12 Impact factor: 5.209
Authors: Guangxia Chen; Wan Feng; Shu Zhang; Kangqi Bian; Yan Yang; Cheng Fang; Min Chen; Jun Yang; Xiaoping Zou Journal: Am J Cancer Res Date: 2015-03-15 Impact factor: 6.166
Authors: Zheng Chen; Mohammed Soutto; Bushra Rahman; Muhammad W Fazili; DunFa Peng; Maria Blanca Piazuelo; Heidi Chen; M Kay Washington; Yu Shyr; Wael El-Rifai Journal: Genes Chromosomes Cancer Date: 2017-04-04 Impact factor: 5.006
Authors: Tara R Semenkovich; Yan Yan; Melanie Subramanian; Bryan F Meyers; Benjamin D Kozower; Ruben Nava; G Alexander Patterson; Daniel Kreisel; Varun Puri Journal: Ann Surg Date: 2021-06-01 Impact factor: 13.787